These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27857212)

  • 1. GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A.
    Barcala Tabarrozzi AE; Andreone L; Deckers J; Castro CN; Gimeno ML; Ariolfo L; Berguer PM; Antunica-Noguerol M; Liberman AC; Vettorazzi S; Tuckermann JP; De Bosscher K; Perone MJ
    Sci Rep; 2016 Nov; 6():36646. PubMed ID: 27857212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Zheng Y; Ishiguro H; Ide H; Inoue S; Kashiwagi E; Kawahara T; Jalalizadeh M; Reis LO; Miyamoto H
    Mol Endocrinol; 2015 Oct; 29(10):1486-97. PubMed ID: 26322830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.
    Lesovaya EA; Yemelyanov AY; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Biochemistry (Mosc); 2011 Nov; 76(11):1242-52. PubMed ID: 22117551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of maturation states of rat bone marrow-derived dendritic cells using an improved culture technique.
    Grauer O; Wohlleben G; Seubert S; Weishaupt A; Kämpgen E; Gold R
    Histochem Cell Biol; 2002 Apr; 117(4):351-62. PubMed ID: 11976908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autophagy receptor SQSTM1/p62 mediates anti-inflammatory actions of the selective NR3C1/glucocorticoid receptor modulator compound A (CpdA) in macrophages.
    Mylka V; Deckers J; Ratman D; De Cauwer L; Thommis J; De Rycke R; Impens F; Libert C; Tavernier J; Vanden Berghe W; Gevaert K; De Bosscher K
    Autophagy; 2018; 14(12):2049-2064. PubMed ID: 30215534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
    Labeur MS; Roters B; Pers B; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jan; 162(1):168-75. PubMed ID: 9886383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis.
    Rauner M; Thiele S; Sinningen K; Winzer M; Salbach-Hirsch J; Gloe I; Peschke K; Haegeman G; Tuckermann JP; Hofbauer LC
    Endocrinology; 2013 Oct; 154(10):3719-28. PubMed ID: 23885015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.
    Wüst S; Tischner D; John M; Tuckermann JP; Menzfeld C; Hanisch UK; van den Brandt J; Lühder F; Reichardt HM
    PLoS One; 2009 Dec; 4(12):e8202. PubMed ID: 19997594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro.
    Lutz MB; Kukutsch NA; Menges M; Rössner S; Schuler G
    Eur J Immunol; 2000 Apr; 30(4):1048-52. PubMed ID: 10760792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.
    Saksida T; Vujicic M; Nikolic I; Stojanovic I; Haegeman G; Stosic-Grujicic S
    Br J Pharmacol; 2014 Dec; 171(24):5898-909. PubMed ID: 25158597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells.
    Rauner M; Goettsch C; Stein N; Thiele S; Bornhaeuser M; De Bosscher K; Haegeman G; Tuckermann J; Hofbauer LC
    Endocrinology; 2011 Jan; 152(1):103-12. PubMed ID: 21084452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I
    Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Anti-Cancer Activity of the Novel Selective Glucocorticoid Receptor Agonists of the Phenylethanolamine Series.
    Zhidkova EM; Tilova LR; Fetisov TI; Kirsanov KI; Kulikov EP; Enikeev AD; Budunova IV; Badun GA; Chernysheva MG; Shirinian VZ; Yakubovskaya MG; Lesovaya EA
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF Requires the Receptor NRP-1 To Inhibit Lipopolysaccharide-Dependent Dendritic Cell Maturation.
    Oussa NA; Dahmani A; Gomis M; Richaud M; Andreev E; Navab-Daneshmand AR; Taillefer J; Carli C; Boulet S; Sabbagh L; Labrecque N; Sapieha P; Delisle JS
    J Immunol; 2016 Nov; 197(10):3927-3935. PubMed ID: 27815442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible separation of 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation and hyperplasia by compound A.
    Kowalczyk P; Kowalczyk MC; Junco JJ; Tolstykh O; Kinjo T; Truong H; Walaszek Z; Hanausek M; Slaga TJ
    Mol Carcinog; 2013 Jun; 52(6):488-96. PubMed ID: 22351517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow.
    Bleier JI; Pillarisetty VG; Shah AB; DeMatteo RP
    J Immunol; 2004 Jun; 172(12):7408-16. PubMed ID: 15187118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS/TLR4-dependent induction by Salmonella Enteritidis.
    Siegemund S; Schütze N; Freudenberg MA; Lutz MB; Straubinger RK; Alber G
    Immunobiology; 2007; 212(9-10):739-50. PubMed ID: 18086375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands.
    Idoyaga J; Moreno J; Bonifaz L
    Cancer Immunol Immunother; 2007 Aug; 56(8):1237-50. PubMed ID: 17237931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells.
    Hu X; Zafar MI; Gao F
    Drug Des Devel Ther; 2015; 9():4847-60. PubMed ID: 26346531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.